Viewing Study NCT00094341



Ignite Creation Date: 2024-05-05 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00094341
Status: COMPLETED
Last Update Posted: 2008-12-05
First Post: 2004-10-16

Brief Title: Preference of Rheumatoid Arthritis RA Patients of Enbrel Etanercept Auto-Injector Versus Enbrel Pre-Filled Syringes
Sponsor: Amgen
Organization: Amgen

Study Overview

Official Title: An Open-Label Randomized Crossover Study to Assess Preference of Rheumatoid Arthritis RA Patients of Enbrel Etanercept Auto-Injector Versus Enbrel Pre-Filled Syringes
Status: COMPLETED
Status Verified Date: 2008-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine the preference of RA patients for the new Enbrel etanercept pre-filled syringe in patients who are already taking Enbrel
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None